Altox

Database / Pharmaceutical impurity

Pharmaceutical impurity

Drospirenone impurity E

Drospirenone impurity E is listed in the pharmaceutical impurity collection under CAS 90457-65-1. Its represented structure has formula C24H30O3 and a calculated molecular weight of 366.50 g/mol.

2D chemical structure

O O O H H H H H H H ( R ) ( R ) ( R ) ( R ) ( S ) ( S ) ( S ) ( R ) ( S ) ( S )

Chemical identity

Catalog name
Drospirenone impurity E
Common name
Drospirenone impurity E
Chemical name
Not available
CAS
90457-65-1
SMILES
C[C@]12CCC(=O)C=C1[C@@H]1C[C@@H]1[C@H]1[C@@H]3[C@@H]4C[C@@H]4[C@]4(CCC(=O)O4)[C@@]3(C)CC[C@@H]12
InChI
InChI=1S/C24H30O3/c1-22-6-3-12(25)9-17(22)13-10-14(13)20-16(22)4-7-23(2)21(20)15-11-18(15)24(23)8-5-19(26)27-24/h9,13-16,18,20-21H,3-8,10-11H2,1-2H3/t13-,14+,15-,16+,18+,20-,21+,22-,23+,24-/m1/s1
InChIKey
METQSPRSQINEEU-BCOSXLPSSA-N
Associated API
Drospirenone

Record ID: A5dc823f68cff

Computed properties

C24H30O3 Molecular formula
366.501 g/molMolecular weight
366.2195 DaMonoisotopic exact mass
43.37 ŲTopological polar surface area
4.3059 Calculated LogP (Wildman–Crippen)
99.493 cm³/molMolar refractivity (Wildman–Crippen)
3 countHydrogen-bond acceptors
0 countHydrogen-bond donors

Descriptors are calculated from the displayed SMILES. Calculated LogP is not a measured partition coefficient or a pH-specific LogD.

Molecular descriptor profile

Descriptor radar

Mol. weight LogP TPSA HBA HBD Rotatable 25 50 75 100

Structural feature counts

0 3 6 9 Count H-bond acceptors H-bond donors Rotatable bonds Rings Aromatic rings Stereo centers

Element composition

C H O 0 8 16 24 Number of atoms

Radar scale: 0–100 percentile within 25,771 distinct represented structures in this release, using the midpoint rank for ties. Larger values indicate a higher descriptor rank, not greater safety or toxicity. Element counts include hydrogen and combine isotopes under each element.

Radar values and percentile reference
DescriptorValuePercentile
Molecular weight366.50161.78
Calculated LogP (Wildman–Crippen)4.305982.32
Topological polar surface area43.3725.37
Hydrogen-bond acceptors333.13
Hydrogen-bond donors011.28
Rotatable bonds (strict)03.45

Complete molecular descriptors

PropertyCalculated valueUnit / type
Molecular formulaC24H30O3dimensionless
Molecular weight366.501g/mol
Monoisotopic exact mass366.2195Da
Topological polar surface area43.37Ų
Calculated LogP (Wildman–Crippen)4.3059dimensionless
Molar refractivity (Wildman–Crippen)99.493cm³/mol
Hydrogen-bond acceptors3count
Hydrogen-bond donors0count
Rotatable bonds (strict)0count
Heavy atoms27count
Heteroatoms3count
Rings7count
Aromatic rings0count
Aliphatic rings7count
Saturated rings6count
Aromatic heterocycles0count
Aliphatic heterocycles1count
Saturated heterocycles1count
Aromatic carbocycles0count
Aliphatic carbocycles6count
Fraction of sp³ carbon atoms0.8333fraction
Formal charge0e
Disconnected components1count
Isotopically specified atoms0count
Potential atom stereocenters10count
Unspecified atom stereocenters0count
Spiro atoms1count
Bridgehead atoms0count
Labute approximate surface area160.8391Ų
Valence electrons144count
Radical electrons0count
Bertz complexity827.4829index
Balaban J1.3335index

Ring categories overlap and should not be summed. No toxicity result, PDE, HBEL or acceptable intake is inferred from these descriptors.

Toxicological services and resources for Drospirenone impurity E

Qualification and safety assessment of Drospirenone impurity E

Explore toxicological qualification of Drospirenone impurity E and ICH M7 mutagenic impurity assessment of Drospirenone impurity E for evaluation of this impurity in its pharmaceutical context.

Where data gaps need to be addressed, resources include read-across assessment for Drospirenone impurity E and acceptable intake and limit justification for Drospirenone impurity E. The relevant approach depends on the available evidence, exposure and duration of use.

Related Altox services and technical resources

Other catalogue designations with the same represented structure

These are separate catalogue entries; shared structure does not establish interchangeable pharmacopoeial designations.

Identity sources and calculation method

Identifiers originate from the source catalogues and available public identity records. InChI and InChIKey on this page are generated from the displayed SMILES. RDKit validation checks the molecular representation; it does not independently verify every catalogue assignment.

Discuss an assessment for Drospirenone impurity E

Explore Altox services and software through the Altox Pharma-Hub.